Scott A. Smith serves as the Chief Executive Officer of Viatris Inc., a global healthcare company that focuses on improving access to high-quality medicines worldwide. With an extensive background in the pharmaceutical industry, Smith brings a wealth of experience and leadership to his role at Viatris. Prior to joining Viatris, he held various senior executive positions at Celgene Corporation, where he was instrumental in driving the company's growth and success. His strategic vision and deep understanding of the healthcare sector have been crucial in shaping Viatris' mission to empower people worldwide to live healthier at every stage of life. At Viatris, Scott A. Smith has been pivotal in steering the company through a transformative period following its formation through the merger of Mylan N.V. and Pfizer's Upjohn business. Under his leadership, Viatris has focused on enhancing its global reach and diversifying its product portfolio to address a wide range of therapeutic areas. Smith's commitment to innovation and patient-centric solutions has positioned Viatris as a key player in the global healthcare landscape. His strategic initiatives have not only strengthened the company's market position but also reinforced its dedication to delivering affordable and accessible healthcare solutions to patients around the world. In addition to his role at Viatris, Scott A. Smith is recognized for his contributions to the broader healthcare industry. He is actively involved in various industry associations and initiatives aimed at advancing healthcare innovation and improving patient outcomes. His leadership style emphasizes collaboration, integrity, and a relentless focus on value creation, which has earned him respect and admiration from colleagues and peers alike. As CEO of Viatris, Smith continues to drive the company's growth and impact, ensuring that it remains at the forefront of the global effort to enhance healthcare accessibility and quality.